Results for tag: "Yervoy"

Yervoy (Ipilimumab) is a drug used to treat advanced stages of non-small cell lung cancer (NSCLC). It is a monoclonal antibody that works by targeting a protein called cytotoxic T-lymphocyte antigen 4 (CTLA-4). This protein is found on the surface of T-cells, which are a type of white blood cell that helps the body fight off infections. By blocking CTLA-4, Yervoy helps the body's immune system to recognize and attack cancer cells. Yervoy is approved by the US Food and Drug Administration (FDA) for the treatment of advanced NSCLC in combination with other drugs. It is also approved for the treatment of melanoma, a type of skin cancer. Yervoy is manufactured by Bristol-Myers Squibb, a global biopharmaceutical company. Other companies in the market include Merck, AstraZeneca, and Roche. Show Less Read more